VESNUA Trademark

Trademark Overview

On Thursday, January 16, 2020, a trademark application was filed for VESNUA with the United States Patent and Trademark Office. The USPTO has given the VESNUA trademark a serial number of 88761616. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 31, 2023. This trademark is owned by Pfizer Inc.. The VESNUA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations and smoking cessation preparations; vaccines for human use
vesnua

General Information

Serial Number88761616
Word MarkVESNUA
Filing DateThursday, January 16, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 31, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 5, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations and smoking cessation preparations; vaccines for human use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, January 22, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 100012192
Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Monday, July 31, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 31, 2023ABANDONMENT - NO USE STATEMENT FILED
Tuesday, March 28, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, March 28, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 28, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, December 15, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 14, 2022SOU EXTENSION 5 GRANTED
Friday, December 2, 2022SOU EXTENSION 5 FILED
Wednesday, December 14, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, December 2, 2022TEAS EXTENSION RECEIVED
Saturday, June 4, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 2, 2022SOU EXTENSION 4 GRANTED
Thursday, June 2, 2022SOU EXTENSION 4 FILED
Thursday, June 2, 2022TEAS EXTENSION RECEIVED
Friday, December 10, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 8, 2021SOU EXTENSION 3 GRANTED
Wednesday, December 8, 2021SOU EXTENSION 3 FILED
Wednesday, December 8, 2021TEAS EXTENSION RECEIVED
Friday, June 11, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 9, 2021SOU EXTENSION 2 GRANTED
Wednesday, June 9, 2021SOU EXTENSION 2 FILED
Wednesday, June 9, 2021TEAS EXTENSION RECEIVED
Thursday, November 5, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 3, 2020SOU EXTENSION 1 GRANTED
Tuesday, November 3, 2020SOU EXTENSION 1 FILED
Tuesday, November 3, 2020TEAS EXTENSION RECEIVED
Tuesday, June 30, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 5, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 5, 2020PUBLISHED FOR OPPOSITION
Wednesday, April 15, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, March 28, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 27, 2020ASSIGNED TO EXAMINER
Tuesday, February 4, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 4, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, January 30, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, January 30, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, January 22, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, January 20, 2020NEW APPLICATION ENTERED

Related Keywords

vesnua preparations disorders pharmaceutical dysfunction treatment liver erectile blood viral urological